The course of insomnia in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 33, Issue , 2016, Pages 51-57

  Zhu, Kangdi ^a   van Hilten, Jacobus J ^a   Marinus, Johan ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Insomnia; Parkinson's disease; Risk factors

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; HYPNOTIC AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DISEASE COURSE; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; INSOMNIA; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; PARKINSON DISEASE; PATHOPHYSIOLOGY; POST HOC ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SYMPTOM; AGED; COMPLICATION; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL;

AGED; COHORT STUDIES; FEMALE; HUMANS; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PARKINSON DISEASE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 84994813326     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2016.09.010     Document Type: Article

References (40)

1. [1] Gjerstad, M.D., Wentzel Larsen, T., Aarsland, D., Larsen, J.P., Insomnia in Parkinson's disease: frequency and progression over time. J. Neurol. Neurosurg. Psychiatry 78 (2007), 476–479.
2. [2] International Classification of Sleep Disorders, third ed., 2014, American Academy of Sleep Medicine, Darien.
3. [3] Verbaan, D., van Rooden, S.M., Visser, M., Marinus, J., van Hilten, J.J., Nighttime sleep problems and daytime sleepiness in Parkinson's disease. Mov. Disord. 23 (2008), 35–41.
4. [4] Chahine, L.M., Daley, J., Horn, S., Duda, J.E., Colcher, A., Hurtig, H., Cantor, C., Dahodwala, N., Association between dopaminergic medications and nocturnal sleep in early-stage Parkinson's disease. Park. Relat. Disord. 19 (2013), 859–863.
5. [5] Duncan, G.W., Khoo, T.K., Yarnall, A.J., O'Brien, J.T., Coleman, S.Y., Brooks, D.J., Barker, R.A., Burn, D.J., Health-related quality of life in early Parkinson's disease: the impact of nonmotor symptoms. Mov. Disord. 29 (2014), 195–202.
6. [6] Forsaa, E.B., Larsen, J.P., Wentzel-Larsen, T., Herlofson, K., Alves, G., Predictors and course of health-related quality of life in Parkinson's disease. Mov. Disord. 23 (2008), 1420–1427.
7. [7] Martinez-Martin, P., Schapira, A.H., Stocchi, F., Sethi, K., Odin, P., MacPhee, G., Brown, R.G., Naidu, Y., Clayton, L., Abe, K., Tsuboi, Y., MacMahon, D., Barone, P., Rabey, M., Bonuccelli, U., Forbes, A., Breen, K., Tluk, S., Olanow, C.W., Thomas, S., Rye, D., Hand, A., Williams, A.J., Ondo, W., Chaudhuri, K.R., Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov. Disord. 22 (2007), 1623–1629.
8. [8] Barone, P., Antonini, A., Colosimo, C., Marconi, R., Morgante, L., Avarello, T.P., Bottacchi, E., Cannas, A., Ceravolo, G., Ceravolo, R., Cicarelli, G., Gaglio, R.M., Giglia, R.M., Lemolo, F., Manfredi, M., Meco, G., Nicoletti, A., Pederzoli, M., Petrone, A., Pisani, A., Pontieri, F.E., Quatrale, R., Ramat, S., Scala, R., Volpe, G., Zappulla, S., Bentivoglio, A.R., Stocchi, F., Trianni, G., Dotto, P.D., PRIAMO study group, the PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov. Disord. 24 (2009), 1641–1649.
9. [9] Borek, L.L., Kohn, R., Friedman, J.H., Mood and sleep in Parkinson's disease. J. Clin. Psychiatry 67 (2006), 958–963.
10. [10] Happe, S., Lüdemann, P., Berger, K., FAQT study investigators, the association between disease severity and sleep-related problems in patients with Parkinson's disease. Neuropsychobiology 46 (2002), 90–96.
11. [11] Kurtis, M.M., Rodriguez-Blazquez, C., Martinez-Martin, P., ELEP Group, Relationship between sleep disorders and other non-motor symptoms in Parkinson's disease. Park. Relat. Disord. 19 (2013), 1152–1155.
12. [12] Scullin, M.K., Sollinger, A.B., Land, J., Wood-Siverio, C., Zanders, L., Lee, R., Freeman, A., Goldstein, F.C., Bliwise, D.L., Factor, S.A., Sleep and impulsivity in Parkinson's disease. Park. Relat. Disord. 19 (2013), 991–994.
13. [13] Zhu, K., van Hilten, J.J., Putter, H., Marinus, J., Risk factors for hallucinations in Parkinson's disease: results from a large prospective cohort study. Mov. Disord. 28 (2013), 755–762.
14. [14] Verbaan, D., Marinus, J., Visser, M., van Rooden, S.M., Stiggelbout, A.M., van Hilten, J.J., Patient-reported autonomic symptoms in Parkinson disease. Neurology 69 (2007), 333–341.
15. [15] Gibb, W.R., Lees, A.J., The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 51 (1988), 745–752.
16. [16] Esselink, R.A., de Bie, R.M., de Haan, R.J., Lenders, M.W., Nijssen, P.C., Staal, M.J., Smeding, H.M., Schuurman, P.R., Bosch, D.A., Speelman, J.D., Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: a randomized trial. Neurology 62 (2004), 201–207.
17. [17] Hoehn, M.M., Yahr, M.D., Parkinsonism: onset, progression, and mortality 1967. Neurology 57 (2001), S11–S26.
18. [18] Marinus, J., Visser, M., Stiggelbout, A.M., Rabey, J.M., Martínez-Martín, P., Bonuccelli, U., Kraus, P.H., van Hilten, J.J., A short scale for the assessment of motor impairments and disabilities in Parkinson's disease: the SPES/SCOPA. J. Neurol. Neurosurg. Psychiatry 75 (2004), 388–396.
19. [19] Verbaan, D., Marinus, J., Visser, M., van Rooden, S.M., Stiggelbout, A.M., Middelkoop, H.A., van Hilten, J.J., Cognitive impairment in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 78 (2007), 1182–1187.
20. [20] Visser, M., Verbaan, D., van Rooden, S.M., Stiggelbout, A.M., Marinus, J., van Hilten, J.J., Assessment of psychiatric complications in Parkinson's disease: the SCOPA-PC. Mov. Disord. 22 (2007), 2221–2228.
21. [21] Visser, M., Marinus, J., Stiggelbout, A.M., van Hilten, J.J., Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA-AUT. Mov. Disord. 19 (2004), 1306–1312.
22. [22] Marinus, J., Visser, M., van Hilten, J.J., Lammers, G.J., Stiggelbout, A.M., Assessment of sleep and sleepiness in Parkinson disease. Sleep 26 (2003), 1049–1054.
23. [23] Beck, A.T., Ward, C.H., Mendelson, M., Mock, J., Erbaugh, J., An inventory for measuring depression. Arch. Gen. Psychiatry 4 (1961), 53–63.
24. [24] Jankovic, J., McDermott, M., Carter, J., Gauthier, S., Goetz, C., Golbe, L., Huber, S., Koller, W., Olanow, C., Shoulson, I., et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40 (1990), 1529–1534.
25. [25] Högl, B., Arnulf, I., Comella, C., Ferreira, J., Iranzo, A., Tilley, B., Trenkwalder, C., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G.T., Schrag, A., Goetz, C.G., Scales to assess sleep impairment in Parkinson's disease: critique and recommendations. Mov. Disord. 25 (2010), 2704–2716.
26. [26] Garcia-Borreguero, D., Larrosa, O., Bravo, M., Parkinson's disease and sleep. Sleep. Med. Rev. 7 (2003), 115–129.
27. [27] Lees, A.J., Blackburn, N.A., Campbell, V.L., The nighttime problems of Parkinson's disease. Clin. Neuropharmacol. 6 (1988), 512–519.
28. [28] Videnovic, A., Willis, G.L., Circadian system - a novel diagnostic and therapeutic target in Parkinson's disease?. Mov. Disord. 31 (2016), 260–269.
29. [29] Diagnostic and Statistical Manual of Mental Disorders, fourth ed., 2000, American Psychiatric Association.
30. [30] Zhu, K., van Hilten, J.J., Marinus, J., Associated and predictive factors of depressive symptoms in patients with Parkinson's disease. J. Neurol. 263 (2016), 1215–1225.
31. [31] Rodrigues, T.M., Castro Caldas, A., Ferreira, J.J., Pharmacological interventions for daytime sleepiness and sleep disorders in Parkinson's disease: systematic review and meta-analysis. Park. Relat. Disord. 27 (2016), 25–34.
32. [32] Van den Kerchove, M., Jacquy, J., Gonce, M., De Deyn, P.P., Sustained-release levodopa in parkinsonian patients with nocturnal disabilities. Acta Neurol. Belg. 93 (1993), 32–39.
33. [33] Stocchi, F., Barbato, L., Nordera, G., Berardelli, A., Ruggieri, S., Sleep disorders in Parkinson's disease. J. Neurol. 245 (1998), S15–S18.
34. [34] van Hilten, B., Hoff, J.I., Middelkoop, H.A., van der Velde, E.A., Kerkhof, G.A., Wauquier, A., Kamphuisen, H.A., Roos, R.A., Sleep disruption in Parkinson's disease. Assessment by continuous activity monitoring. Arch. Neurol. 51 (1994), 922–928.
35. [35] Rascol, O., Perez-Lloret, S., Ferreira, J.J., New treatments for levodopa-induced motor complications. Mov. Disord. 30 (2015), 1451–1460.
36. [36] Barone, P., Amboni, M., Vitale, C., Bonavita, V., Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. Neurology 63 (2004), S35–S38.
37. [37] Yeo, L., Singh, R., Gundeti, M., Barua, J.M., Masood, J., Urinary tract dysfunction in Parkinson's disease: a review. Int. Urol. Nephrol. 44 (2012), 415–424.
38. [38] Goldstein, D.S., Dysautonomia in Parkinson's disease: neurocardiological abnormalities. Lancet Neurol. 2 (2003), 669–676.
39. [39] Rye, D.B., Jankovic, J., Emerging views of dopamine in modulating sleep/wake state from an unlikely source, PD. Neurology 58 (2002), 341–346.
40. [40] Palma, J.A., Urrestarazu, E., Alegre, M., Pastor, M.A., Valencia, M., Artieda, J., Iriarte, J., Cardiac autonomic impairment during sleep is linked with disease severity in Parkinson's disease. Clin. Neurophysiol. 124 (2013), 1163–1168.